Table.1 Demographic, clinical, and imaging features of the patients
Variable | Categories/feature | Positive cases | P value | ||||
|---|---|---|---|---|---|---|---|
Total N (%) | < 1 n (%) | 1–5 n (%) | 6–10 n (%) | 11–18 n (%) | |||
Age (years) | < 1 | 8 (72.7%) | – | – | – | – | – |
1–5 | 15 (100.0%) | – | – | – | – | ||
6–10 | 15 (71.4%) | – | – | – | – | ||
11–18 | 11 (73.3%) | – | – | – | – | ||
Exposure | Confirmed family member | 10 (20.4%) | 1 (12.5%) | 4 (26.7%) | 3 (20.0%) | 2 (18.2%) | 0.677ǂ |
Suspect family member | 14 (28.6%) | 3 (37.5%) | 4 (26.7%) | 4 (26.7%) | 3 (27.3%) | ||
Unknown source | 20 (40.8%) | 2 (25.0%) | 7 (46.7%) | 7 (46.7 %) | 4 (36.4%) | ||
Contact with other suspects | 3 (6.1%) | 2 (25.0%) | 0 (0.0%) | 0 (0.0%) | 1 (9.1%) | ||
Not-mentioned | 2 (4.1%) | 0 (0.0%) | 0 (0.0%) | 1 (6.7%) | 1 (9.1%) | ||
Diagnosis | Asymptotic infection | 11 (22.4%) | 4 (50.0%) | 3 (20.0%) | 1 (6.7%) | 3 (27.3%) | 0.097ǂ |
URTI | 14 (28.6%) | 1 (12.5%) | 6 (40.0%) | 4 (26.7 %) | 3 (27.3%) | 0.629ǂ | |
Pneumonia | 37 (75.5%) | 5 (62.5%) | 13 (86.7%) | 13 (86.7%) | 6 (54.5%) | 0.194ǂ | |
Clinical findings | Fever | 47 (95.9%) | 8 (100.0%) | 14 (93.3%) | 15 (100.0%) | 10 (90.9%) | 0.839ǂ |
Cough | 31 (63.3%) | 4 (50.0%) | 12 (80.0%) | 10 (66.7%) | 5 (45.5%) | 0.263† | |
Tachypneaa | 29 (59.2%) | 5 (62.5%) | 7 (46.7%) | 11 (73.3%) | 6 (54.5%) | 0.503† | |
Blood oxygen saturation < 92 % | 27 (55.1%) | 6 (75.0%) | 5 (33.3%) | 9 (60.0%) | 7 (63.6%) | 0.202† | |
Tachycardiaa | 25 (51.0%) | 6 (75.0%) | 5 (33.3%) | 8 (53.3%) | 6 (54.5%) | 0.283† | |
Pharyngeal erythema | 24 (49.0%) | 2 (25.0%) | 9 (60.0%) | 6 (40.0%) | 7 (63.6%) | 0.262† | |
Fatigue | 20 (40.8%) | 0 (0.0%) | 3 (20.0%) | 10 (66.7%) | 7 (63.6%) | 0.002†* | |
Vomiting | 20 (40.8%) | 3 (37.5%) | 4 (26.7%) | 7 (46.7%) | 6 (54.5%) | 0.503† | |
Diarrhea | 16 (32.7%) | 4 (50.0%) | 3 (20.0%) | 4 (26.7%) | 5 (45.5%) | 0.355† | |
Nasal congestion | 15 (30.6%) | 3 (37.5%) | 3 (20.0%) | 5 (33.3%) | 4 (36.4%) | 0.742ǂ | |
Runny nose | 15 (30.6%) | 1 (12.5%) | 6 (40.0%) | 4 (26.7%) | 4 (36.4%) | 0.548ǂ | |
Chest X-ray | Bilateral haziness | 20 940.8%) | 2 (25.0%) | 6 (40.0%) | 7 (46.7%) | 5 (45.5%) | 0.767† |
Peripheral opacity | 15 (30.6%) | 2 (25.0%) | 5 (33.3%) | 5 (33.3%) | 3 (27.3%) | 0.964† | |
Chest CT scan | Ground-glass opacity | 29 (59.2%) | 3 (37.5%) | 12 (80.0%) | 9 (60.0%) | 5 (45.5%) | 0.164† |
Local patchy shadowing | 5 (10.2%) | 1 (12.5%) | 0 (0.0%) | 2 (13.3%) | 2 (18.2%) | 0.565ǂ | |
Bilateral patchy shadowing | 11 (22.4%) | 2 (25.0%) | 2 (13.3%) | 3 (20.0%) | 4 (36.4%) | 0.726ǂ | |
Interstitial abnormalities | 11 (22.4%) | 2 (25.0%) | 4 (26.7%) | 3 (20.0%) | 2 (18.2%) | 0.999ǂ | |
Neurological signs | Reduced consciousness | 10 (20.4%) | 2 (25.0%) | 1 (6.7%) | 5 (33.3%) | 2 (18.2%) | 0.403ǂ |
Seizure | 9 (18.4%) | 4 (50.0%) | 2 (13.3%) | 2 (13.3%) | 1 (9.1%) | 0.129ǂ | |
Total symptoms | 21 (42.9%) | 4 (50.0%) | 12 (80.0%) | 5 (33.3%) | 7 (63.6%) | 0.097ǂ | |
Liver involvement | 15 (30.6%) | 2 (25.0%) | 6 (40.0%) | 4 (26.7%) | 3 (27.3%) | 0.823† | |